Financial reports
20-F
2022 FY
Annual report (foreign)
31 Jul 23
20-F
2022 FY
Annual report (foreign)
1 Aug 22
20-F/A
2021 FY
Annual report (foreign) (amended)
3 Mar 22
20-F
2021 FY
Annual report (foreign)
29 Jul 21
20-F/A
2020 FY
Annual report (foreign) (amended)
26 Mar 21
20-F
2020 FY
Annual report (foreign)
18 Aug 20
NT 20-F
Notice of late annual filing (foreign)
31 Jul 20
20-F
2019 FY
Annual report (foreign)
27 Dec 19
NT 20-F
Notice of late annual filing (foreign)
31 Jul 19
20-F
2018 FY
Annual report (foreign)
30 Jul 18
Current reports
6-K
Portage Biotech Announces Plans to Expand its Evaluation of Strategic Alternatives
12 Apr 24
6-K
Current report (foreign)
8 Mar 24
6-K
Current report (foreign)
6 Mar 24
6-K
Company focused on adenosine platform clinical development
28 Feb 24
6-K
Current report (foreign)
28 Feb 24
6-K
Current report (foreign)
18 Jan 24
6-K
Current report (foreign)
4 Jan 24
6-K
PORT 2 and 6 Presented at the Society for Immunotherapy of Cancer’s (SITC) Annual Meeting
28 Nov 23
6-K
Current report (foreign)
28 Nov 23
6-K
Current report (foreign)
13 Nov 23
Registration and prospectus
424B3
Prospectus supplement
12 Apr 24
424B3
Prospectus supplement
8 Mar 24
424B3
Prospectus supplement
6 Mar 24
424B3
Prospectus supplement
28 Feb 24
424B3
Prospectus supplement
18 Jan 24
424B3
Prospectus supplement
4 Jan 24
S-8
Registration of securities for employees
1 Dec 23
424B3
Prospectus supplement
28 Nov 23
424B3
Prospectus supplement
14 Nov 23
424B3
Prospectus supplement
7 Nov 23
Proxies
No filings
Other
EFFECT
Notice of effectiveness
8 Nov 23
CORRESP
Correspondence with SEC
3 Nov 23
UPLOAD
Letter from SEC
3 Nov 23
UPLOAD
Letter from SEC
14 Mar 22
UPLOAD
Letter from SEC
17 Feb 22
EFFECT
Notice of effectiveness
9 Mar 21
CORRESP
Correspondence with SEC
5 Mar 21
CORRESP
Correspondence with SEC
5 Mar 21
UPLOAD
Letter from SEC
4 Mar 21
CERT
Certification of approval for exchange listing
24 Feb 21
Ownership
SC 13G
ARMISTICE CAPITAL, LLC
14 Feb 24
SC 13D/A
Portage Biotech Inc.
22 Jan 19
SC 13D/A
Portage Biotech Inc.
22 Jan 19
4/A
Biohaven Pharmaceutical Holding Co Ltd.
25 Jan 18
4
Biohaven Pharmaceutical Holding Co Ltd.
24 Jan 18
4/A
Biohaven Pharmaceutical Holding Co Ltd.
11 Jan 18
SC 13D
Portage Biotech Inc.
10 Jan 18
4
Biohaven Pharmaceutical Holding Co Ltd.
9 Jan 18
SC 13D/A
Portage Biotech Inc.
9 Jan 18
SC 13D/A
Portage Biotech Inc.
9 Jan 18